…
Gabriel Mannis, MD Associate Professor of Medicine in the Division of Hematology at Stanford University School of Medicine provides an in-depth analysis of Notable Lab’s Predictive Precision Medicine Platform. Dr. Mannis discusses the pivotal role of PPMP in advancing the treatment of Acute Myeloid Leukemia (AML), focusing on how its rapid and personalized approach can significantly enhance patient outcomes by tailoring therapies to individual needs. For more information visit www.NotableLabs.com
For More Information Visit Notable Lab’s Predictive Precision Medicine Platform